Diligence memo · auto-generated · as of July 2, 2026
Wugen, Inc.
Wugen, Inc. has raised $245M over 3 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Wugen, Inc. operates in Other Health Care, based in St. Louis.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Wugen, Inc. has raised $245M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $109M on 2025-08-22.
Most recent recorded round closed around 2025-08-22.
Valuation (modeled)modeled
Provath models Wugen, Inc. at approximately $871M (range $583M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 32 months.
Last raise 10 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 1.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 99% of Other Health Care peers (5377 compared).
Modeled value ranks above 96% of those peers.
Closest niche peers: VeraDermics, Inc, HeartFlow Holding, Inc., Enable Injections, Inc.
Peoplefiled
22 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.